What Lonza’s $1.2B Buy of Roche Biologics Plant Means for CDMO Market 3/29/2024

Avalo Snags Former Eli Lilly Asset and $185M in Major Pipeline Pivot 3/29/2024

Gamida Restructures Under Ownership of Highbridge Capital Management 3/29/2024

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field of drug discovery. This innovative framework adeptly integrates structured and unstructured knowledge, enhancing the AI-driven exploration of molecular dynamics and interactions.

EU Approves Merck’s Keytruda, Chemo Combo for Lung Cancer 3/28/2024

Akebia’s CKD Anemia Drug Ends Tough Regulatory Path with FDA Approval 3/28/2024

Will the IRA’s Focus on the Pharmaceutical Industry Hurt the World’s Healthcare System Instead of... 3/28/2024

Stoke Announces $125M Public Offering on Heels of Positive Data for Epilepsy Drug 3/28/2024

Altimmune Axes Hepatitis B Program After Phase II Failure, Focuses on Obesity and MASH 3/28/2024

Sanders Blasts Novo Nordisk for ‘Outrageous’ Price of Ozempic, Wegovy 3/28/2024

Boundless Bio Launches $100M IPO to Advance Cancer Therapy Candidates 3/28/2024

How to Set and Maintain Boundaries at Work 3/28/2024

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed, and saving up to 22 lives every year, suggests a modelling study, published online in BMJ Quality & Safety.

The figures, which are based on the assumption that such a system could reduce medication errors by at least 10%, and by as much as 50%, could also save £millions for the NHS, say the researchers.

Novocure Gets Phase III Win in Patients with Brain Metastases from Lung Cancer 3/27/2024

Opinion: AbbVie-Landos Deal Signals Continued Momentum for Next-Gen I&I Drugs 3/27/2024

Nanoscope Claims Phase II Win for Gene Therapy After Changing Primary Endpoint 3/27/2024

Moderna Secures Up to $750M in Funding from Blackstone to Advance Flu Program 3/27/2024

Pfizer Terminates Phase III Sickle Cell Study Due to Slow Patient Recruitment 3/27/2024

Avenzo Closes $150M Oversubscribed Series A-1 to Advance Cancer Therapies 3/27/2024

COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024: GlobalData 3/27/2024